geranylgeranylacetone and Glucose-Intolerance

Beta cell injury due to oxidative stress is a typical etiology of diabetes caused by nutritional excess, but its precise mechanism remains largely elusive. Here, we demonstrate that the microtubule motor KIF12 mediates an antioxidant cascade in beta cells as an intracellular target of excess fat intake or "lipotoxicity." KIF12 knockout mice suffer from hypoinsulinemic glucose intolerance due to increased beta cell oxidative stress. Using this model, we identified an antioxidant signaling cascade involving KIF12 as a scaffold for the transcription factor Sp1. The stabilization of nascent Sp1 appeared to be essential for proper peroxisomal function by enhancing Hsc70 expression, and the pharmacological induction of Hsc70 expression with teprenone counteracted the oxidative stress. Because KIF12 is transcriptionally downregulated by chronic exposure to fatty acids, this antioxidant cascade involving KIF12 and Hsc70 is proposed to be a critical target of nutritional excess in beta cells in diabetes.

Topics: Animals; Antineoplastic Agents; Base Sequence; Diabetes Mellitus; Diterpenes; Gene Expression; Glucose Intolerance; HSC70 Heat-Shock Proteins; Insulin-Secreting Cells; Kinesins; Mice; Mice, Knockout; Molecular Sequence Data; Oxidative Stress; Sequence Analysis, DNA; Signal Transduction; Sp1 Transcription Factor

We evaluated heat shock protein 70 (HSP70) changes in diabetes mellitus (DM) in a nonhuman primate model. To this end, two studies were conducted in DM vervet monkeys. 1) Normal control and streptozotocin-induced DM monkeys (Stz-DM) that were differentiated into moderately or poorly controlled DM by judicious insulin administration were evaluated. Liver was collected at 4, 8, 12, 16, and 20 wk after streptozotocin, exposed to ex vivo heat shock at 42°C, and immunoblotted for heat shock factor 1 (HSF1), HSP70, and phosphorylated HSF1. 2) Spontaneous DM monkeys that were not pharmacologically induced were included in a crossover study of the HSP70-inducing drug geranylgeranylacetone (GGA). GGA at 20 mg/kg was given for 14 days with a 6-wk washout period. Glucose tolerance testing and plasma and muscle HSP70 were the primary outcome measurements. In Stz-DM, hyperglycemia reduced hepatic HSP70 in a dose-dependent fashion. HSF1 was increased in livers of monkeys with Stz-DM, but responses to ex vivo heat shock were impaired vs. normal monkeys. Activation of HSF1 appears to be important, because the phosphorylation change with heat stress was nearly perfectly correlated with HSP70 increases. Impaired HSF1 activation was also seen in Stz-DM after chronic hyperglycemia (>12 wk). In naturally occurring DM, increased circulating HSP70 resulted in significantly improved glucose tolerance and significant, positive trends in other measurements of insulin resistance. No change in muscle HSP70 content was observed. We conclude that increasing HSP70, potentially through targeting hyperglycemia-related deficits in HSF1 induction and activation in the liver, is a potent and viable strategy to improve glucose tolerance.

Topics: Analysis of Variance; Animals; Body Weight; Chlorocebus aethiops; Diabetes Mellitus, Experimental; Diterpenes; DNA-Binding Proteins; Dose-Response Relationship, Drug; Female; Glucose Intolerance; Glycated Hemoglobin; Heat Shock Transcription Factors; Heat Stress Disorders; HSP70 Heat-Shock Proteins; Hyperglycemia; Lipid Metabolism; Liver; Male; Phosphorylation; Transcription Factors